Lack of sex bias in the referral letters for patients with inflammatory bowel disease: a mixed methods evaluation [0.03%]
炎症性肠病患者的转诊信中不存在性别偏见：一种混合方法评估
Sunil Samnani,Yasmin Nasser,Gurprit Girn et al.
Sunil Samnani et al.
Introduction: Women with inflammatory bowel disease (IBD) experience greater delays and misdiagnosis than men. Data from other conditions suggest that sex and/or gender bias in the process of referral to speciality care m...
A multivariable prediction model to stratify risk of 90-day rehospitalization among adults with ulcerative colitis [0.03%]
一种多变量预测模型用于评估溃疡性结肠炎成人患者90天内再次住院的风险分级
Claudia Dziegielewski,Sarang Gupta,Julia Lombardi et al.
Claudia Dziegielewski et al.
Background: Individuals with ulcerative colitis (UC) are frequently re-hospitalized for persistent or recurrent severe disease flares. Accurate prediction of the risk of early re-hospitalization at the time of discharge c...
Artificial intelligence in hepatology: a comparative analysis of ChatGPT-4, Bing, and Bard at answering clinical questions [0.03%]
人工智能在肝病学中的应用：比较分析ChatGPT-4、Bing和Bard回答临床问题的能力
Sama Anvari,Yung Lee,David Shiqiang Jin et al.
Sama Anvari et al.
Background and aims: The role of artificial intelligence (AI) in hepatology is rapidly expanding. However, the ability of AI chat models such as ChatGPT to accurately answer clinical questions remains unclear. This study ...
Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis [0.03%]
胰高糖素样肽-1受体激动剂治疗对非酒精性脂肪肝病患者肝细胞脂变及气球样变消退的影响：系统评价和.meta.分析
Kathryn J Potter,Jackie Phinney,Tasha Kulai et al.
Kathryn J Potter et al.
Background: Non-alcoholic fatty liver disease (NAFLD) is common, can progress to cirrhosis and hepatic decompensation, and has no approved medical therapy in Canada. ...
Current approaches to studying human resting-state function in inflammatory bowel disease [0.03%]
目前用于研究炎症性肠病患者静息状态功能的方法
Theresa A McIver,Charles N Bernstein,Jennifer Kornelsen
Theresa A McIver
Crohn's disease and ulcerative colitis are 2 subtypes of Inflammatory Bowel Disease (IBD). The chronic, alternating periods of relapsing, and remitting inflammation of the gastrointestinal tract that underlie these diseases trigger a range ...
David L Diehl
David L Diehl
Over the past several years, there has been increasing interaction between Hepatology and Endoscopy, mainly facilitated by EUS-guided modalities. There are 4 main areas that have led to the emergence of what has been called "Endohepatology"...
Russell Yanofsky,David T Rubin
Russell Yanofsky
The therapeutic landscape of ulcerative colitis (UC) has undergone significant change over the last 2 decades. While there are multiple new therapies for the management of UC, long-term remission rates remain low, and this may be in part du...
What is first-line and what is second-line therapy in adult patients with moderate to severe Crohn's disease? [0.03%]
中度至重度克罗恩病成人患者的一线和二线治疗分别是什么？
Remo Panaccione
Remo Panaccione
Crohn's disease, a chronic inflammatory bowel disease, necessitates a comprehensive treatment approach tailored to the individual's specific disease characteristics and overall health. Treatment strategies aim to induce and maintain remissi...
Sunil Gupta,Tony He,Jeffrey D Mosko
Sunil Gupta
Large non-pedunculated colorectal polyps ≥20 mm (LNPCPs) constitute approximately 1% of all colorectal polyps and present a spectrum of risks, including overt and covert submucosal invasive cancer (T1 colorectal cancer (CRC)). Importantly,...
Benchmarking in inflammatory bowel disease: lessons from Australia and New Zealand [0.03%]
炎症性肠病的标杆研究：来自澳大利亚和新西兰的启示
Peter Litwin,Jane Andrews
Peter Litwin
Inflammatory bowel disease (IBD) is a complex chronic disease estimated to affect almost 1% of the Western population, where proactive care has largely replaced a reactive approach. Whilst there have also been great strides in new care mode...